Showing 1 - 5 results of 5 for search 'Megan Iammarino', query time: 0.03s Refine Results
  1. 1
    A first-in-human phase I/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.GALGT2

    A first-in-human phase I/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.GALGT2 by Kevin M. Flanigan, Tatyana A. Vetter, Tabatha R. Simmons, Megan Iammarino, Emma C. Frair, Federica Rinaldi, Louis G. Chicoine, Johan Harris, John P. Cheatham, Sharon L. Cheatham, Brian Boe, Megan A. Waldrop, Deborah A. Zygmunt, Davin Packer, Paul T. Martin

    Published 2022-12-01
    Get full text
    Article
  2. 2
    Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy

    Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy by Marielle G. Contesse, Linda P. Lowes, Michelle K. White, Laura Dalle Pazze, Christine McSherry, Lindsay N. Alfano, Megan Iammarino, Natalie Reash, Kelly Bonarrigo, Michael Kiefer, Katie Laubscher, Melissa McIntyre, Shelley Mockler, Leslie Nelson, Leslie Vogel, Mindy G. Leffler

    Published 2022-01-01
    Get full text
    Article
  3. 3
    Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy.

    Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy. by Marielle G Contesse, Linda P Lowes, Michelle K White, Laura Dalle Pazze, Christine McSherry, Lindsay N Alfano, Megan Iammarino, Natalie Reash, Kelly Bonarrigo, Michael Kiefer, Katie Laubscher, Melissa McIntyre, Shelley Mockler, Leslie Nelson, Leslie Vogel, Mindy G Leffler

    Published 2022-01-01
    Get full text
    Article
  4. 4
    WiTNNess: An international natural history study of infantile‐onset TNNT1 myopathy

    WiTNNess: An international natural history study of infantile‐onset TNNT1 myopathy by Kevin A. Strauss, Vincent J. Carson, Emilienne Bolettieri, Mariah Everett, Ashton Bollinger, Lauren E. Bowser, Keturah Beiler, Millie Young, Simon Edvardson, Nitay Fraenkel, Adele D'Amico, Enrico Bertini, Lokesh Lingappa, Devyani Chowdhury, Linda P. Lowes, Megan Iammarino, Lindsay N. Alfano, Karlla W. Brigatti

    Published 2023-11-01
    Get full text
    Article
  5. 5
    P314: Long-term safety and sustained functional benefit in patients with DMD 4 years post-treatment with delandistrogene moxeparvovec: A phase 1/2a study*

    P314: Long-term safety and sustained functional benefit in patients with DMD 4 years post-treatment with delandistrogene moxeparvovec: A phase 1/2a study* by Erin O’Rourke, Jerry R. Mendell, Zarife Sahenk, Kelly J. Lehman, Linda P. Lowes, Natalie F. Reash, Megan Iammarino, Lindsay Alfano, Sarah Lewis, Kathleen Church, Richard Shell, Rachael A. Potter, Danielle Griffin, Mark J. Hogan, Shufang Wang, Stefanie Mason, Eddie Darton, Louise Rodino-Klapac

    Published 2023-01-01
    Get full text
    Article

Search Tools: